Pricing
  1. US-listed companies
  2. Ampio Pharmaceuticals, Inc.
  3. Financials
  4. Cash and cash equivalents

Ampio Pharmaceuticals, Inc.【AMPE】

Market cap
$317.9K
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 20234-67.60%
Dec 31, 202213-62.68%
Dec 31, 202134+95.95%
Dec 31, 202017+164.85%
Dec 31, 20197-13.89%
Dec 31, 20188-7.60%
Dec 31, 20178+67.71%
Dec 31, 20165-81.84%
Dec 31, 201527-46.43%
Dec 31, 201450+91.26%
Dec 31, 201326+48.79%
Dec 31, 201218+55.62%
Dec 31, 201111

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)